INITIAL Goal is to not miss Red Flag Conditions (Fx, septic or crystal arthritis [all acute monarticular})! Then provid https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg […]
Simple, low-cost strategy to Dx/Prognose GCA using CBC components NLR & PLR. 119 GCA vs 131 non-GCA pts – All
… Rheumatology. Transitioning from denosumab to romosozumab may expose … Giovanni Adami, MD, PhDc, of the University of Verona, Italy,
Conditions: Rheumatic Diseases; Rheumatoid Arthritis (RA) Interventions: Other: Pain Neuroscience Education; Other: Vagal Nerve Stimulation; Other: Structured Exercises Sponsors: Medipol
RHEUM Survey> What is the Sensitivity of the ANA test? https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 12/10/2025 – 11:42 RheumNow Dr. John Cush
OPD Spotter Identify it before the patient even sits Diagnosis ❓ https://t.co/xM90YEp9jZ https://pbs.twimg.com/profile_images/1690863576964386817/RKkaNgOj_normal.jpg john+RNV2@john… Wed, 12/10/2025 – 11:39 docxusofficial DocXus
I agree that multiple assessments are needed to Dx NP-SLE; but my order of preference (for Dx yield) is: A)
British Society of Rheumatology Guideline for Monitoring DMARDs The British Society of Rheumatology has published an u https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed,
The Essential Role of Physician Assistants in Rheumatology Ready to bring a PA into your rheumatology practice? This b https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
One challenge in pediatric rheumatology is that not all diagnostic criteria developed in adults, including the American College of Rheumatology/ …
Ambient listening documentation may soon become integral to clinical practice as AI advances reshape care delivery.Ambient scribes are poised to
Ambient listening documentation may soon become integral to clinical practice as AI advances reshape care delivery.Ambient scribes are poised to
Rheumatologists are not optimizing social media or AI for clinical trials. CHICAGO — Direct-to-patient strategies may be more effective than
QD Clinic: Weakness with Fibromyalgia tammytilley@gm… Wed, 12/10/2025 – 07:00 General Rheumatology Education/ACR/EULAR Fibromyalgia/Pain NP/PA Coverage Jack Cush, MD and
Open Journal of Rheumatology and Autoimmune Diseases, 16, 1-9. doi: 10.4236/ojra.2026.161001. 1. Introduction. Low back pain is the main complaint
Arthritis &Rheumatology, Accepted Article.
Arthritis &Rheumatology, Accepted Article.
Cureus. 2025 Dec 7;17(12):e98670. doi: 10.7759/cureus.98670. eCollection 2025 Dec. ABSTRACT Background and objective Surgical teams are commonly requested to perform
Biologics. 2025 Dec 4;19:713-727. doi: 10.2147/BTT.S555169. eCollection 2025. ABSTRACT PURPOSE: Subcutaneous tocilizumab (SC-TCZ) is approved for rheumatoid arthritis (RA) management.
Saudi J Ophthalmol. 2025 Nov 27;39(4):287-289. doi: 10.4103/sjopt.sjopt_407_25. eCollection 2025 Oct-Dec. NO ABSTRACT PMID:41367846 | PMC:PMC12685255 | DOI:10.4103/sjopt.sjopt_407_25
Saudi J Ophthalmol. 2025 Feb 14;39(4):311-322. doi: 10.4103/sjopt.sjopt_355_24. eCollection 2025 Oct-Dec. ABSTRACT Behçet’s syndrome (BS) is a complex, relapsing inflammatory
Blood Cell Ther. 2025 Oct 24;8(4):274-280. doi: 10.31547/bct-2025-009. eCollection 2025 Nov 25. ABSTRACT Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disease (EBV+
BMJ Neurol Open. 2025 Nov 30;7(2):e001227. doi: 10.1136/bmjno-2025-001227. eCollection 2025. ABSTRACT BACKGROUND: Neurological complications are increasingly recognised in Sjögren’s Syndrome,
Quant Imaging Med Surg. 2025 Dec 1;15(12):11809-11822. doi: 10.21037/qims-2025-974. Epub 2025 Nov 21. ABSTRACT BACKGROUND: Anti-MDA5 antibody-positive dermatomyositis (anti-MDA5 Ab+
Front Immunol. 2025 Nov 24;16:1648290. doi: 10.3389/fimmu.2025.1648290. eCollection 2025. ABSTRACT OBJECTIVE: Substantial progress has been made in understanding the involvement
Osteoarthr Cartil Open. 2025 Oct 15;7(4):100696. doi: 10.1016/j.ocarto.2025.100696. eCollection 2025 Dec. ABSTRACT OBJECTIVE: The success of a randomized controlled trial
Rheumatol Adv Pract. 2025 Nov 14;9(4):rkaf132. doi: 10.1093/rap/rkaf132. eCollection 2025. NO ABSTRACT PMID:41367374 | PMC:PMC12684703 | DOI:10.1093/rap/rkaf132
